CNS Neural Transmitter Panel Screening Service
Welcome to our central nervous system (CNS) Neural Transmitter Panel Screening Service, a specialized laboratory service dedicated to the comprehensive measurement and analysis of key neurotransmitters involved in CNS function. Neurotransmitters are essential for controlling emotion, thought, movement, and many other physiological functions. By understanding the levels of specific neurotransmitters, you can better diagnose and manage neurological and psychiatric conditions such as depression, anxiety, schizophrenia, and neurodegenerative disorders.
Why Do CNS Neural Transmitter Panel Screening
CNS Neural Transmitter Panel Screening is a powerful diagnostic tool that provides crucial insights into the neurochemical status of individuals. Diagnosing and treating a range of neurological and psychiatric conditions requires an understanding of neurotransmitter levels. Here are some key reasons why pursuing this screening can be beneficial:
-
Diagnosis of Neurological and Psychiatric Disorders
-
Monitoring Treatment Effectiveness
-
Enhanced Understanding of Co-occurring Conditions
-
Research and Development Insights
-
Non-Invasive and Convenient Testing Options
Conducting CNS Neural Transmitter Panel Screening is a crucial step in understanding and addressing the complex interplay of neurotransmitters in the brain. Whether for diagnosis, treatment, or research purposes, this screening provides vital information that can lead to more effective and personalized healthcare solutions.
Fig.1 Schematic representation of neurotransmitters.1
CNS Neural Transmitter Panel Screening Service at Creative Biolabs
Our CNS Neural Transmitter Panel Screening Service includes the measurement of a wide range of neurotransmitters, including, but not limited to:
Serotonin: Essential for sleep and mood management.
Dopamine: Associated with motivation, reward, and motor control.
Norepinephrine: Contributes to responsive behavior and attention.
Gamma-Aminobutyric Acid, or GABA, is the main inhibitory neurotransmitter that is necessary to reduce brain activity.
The primary excitatory neurotransmitter, glutamate, is crucial for cognitive processes like memory and learning.
We utilize cutting-edge technology to ensure precise and accurate neurotransmitter measurement:
Liquid Chromatography-Mass Spectrometry (LC-MS): This advanced analytical technique allows for the simultaneous detection and quantification of multiple neurotransmitters with high sensitivity and specificity.
High-Performance Liquid Chromatography (HPLC): This technology enables the separation and accurate measurement of neurotransmitters, ensuring the integrity of the sample analysis.
Automated Data Analysis: Our laboratory employs sophisticated software to process and analyze test results, allowing for efficient and reliable reporting.
Unique Features of Our Services
-
Comprehensive Testing: Our panels are designed to cover a wide range of neurotransmitters, providing a holistic view of CNS chemistry.
-
Customized Options: Clients can tailor the neurotransmitter panel to focus on specific neurotransmitters relevant to their research needs.
-
Rapid Turnaround Time: We prioritize efficiency, providing quick turnaround times for results, typically within 7 to 10 business days.
-
Expert Guidance: Our team of experts is available to provide consultation and interpretation of results, ensuring clients have the support they need for informed clinical decision-making.
Frequently Asked Questions
Q1: How can I interpret the results?
A1: Each report comes with expert analysis and context, and clients are encouraged to schedule a consultation for any questions or additional insight.
Contact Us
Please get in touch with us to arrange a consultation or for more details about our CNS Neural Transmitter Panel Screening Service. We look forward to helping you comprehend and efficiently manage diseases associated to neurotransmitters. Allow us to collaborate with you to further your research or health goals!
Reference
-
Teleanu, Raluca Ioana et al. "Neurotransmitters-Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System." International journal of molecular sciences vol. 23,11 5954. Distributed under Open Access license CC BY 4.0, without modification.
For Research Use Only | Not For Clinical Use
Download our brochure
